Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Normothermic Machine Perfusion as Additional Value to Hypothermic Machine Perfusion for Kidney Transplant Outcomes. A Single-centre, Open-label, Randomised, Controlled Trial.

NCT04882254 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04882254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04882254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Normothermic Machine Perfusion as Additional Value to Hypothermic Machine Perfusion for Kidney Transplant Outcomes. A Single-centre, Open-label, Randomised, Controlled Trial.
Lead sponsor
Erasmus Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2021
Completion date
May 31, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure, kidney transplant failure